Email Updates

You are here

AVAC in the News

  • The trial, called PAVE 100, would have tested whether a vaccine could help control HIV infection. The vaccine regimen was developed by the NIAID’s Vaccine Research Center and comprised a DNA vaccine containing HIV genes, with a modified cold virus carrying HIV genes as a booster.

    July 18, 2008
  • The US National Institutes of Health scrubbed plans to test its AIDS vaccine due to concerns about its safety and effectiveness, 10 months after the collapse of a clinical trial for a similar vaccine from Merck & Co.

    July 18, 2008
    Wall Street Journal